Evergreen Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
14,247
-298
| -2% | -$10.7K | 0.02% | 541 |
|
|
2025
Q1 | $453K | Sell |
14,545
-93,112
| -86% | -$2.9M | 0.02% | 550 |
|
|
2024
Q4 | $2.75M | Sell |
107,657
-149,652
| -58% | -$3.82M | 0.09% | 211 |
|
|
2024
Q3 | $7.28M | Sell |
257,309
-41,008
| -14% | -$1.16M | 0.24% | 119 |
|
|
2024
Q2 | $7.87M | Buy |
298,317
+49,284
| +20% | +$1.3M | 0.28% | 101 |
|
|
2024
Q1 | $7.56M | Buy |
249,033
+6,532
| +3% | +$198K | 0.29% | 99 |
|
|
2023
Q4 | $6.81M | Sell |
242,501
-5,901
| -2% | -$166K | 0.28% | 104 |
|
|
2023
Q3 | $6.74M | Sell |
248,402
-634
| -0.3% | -$17.2K | 0.3% | 104 |
|
|
2023
Q2 | $7.66M | Buy |
249,036
+46,074
| +23% | +$1.42M | 0.32% | 94 |
|
|
2023
Q1 | $7.31M | Buy |
202,962
+97,025
| +92% | +$3.5M | 0.33% | 89 |
|
|
2022
Q4 | $4.19M | Sell |
105,937
-16
| -0% | -$632 | 0.2% | 135 |
|
|
2022
Q3 | $4.26M | Buy |
105,953
+16
| +0% | +$643 | 0.22% | 125 |
|
|
2022
Q2 | $4.45M | Sell |
105,937
-12,619
| -11% | -$531K | 0.23% | 122 |
|
|
2022
Q1 | $4.62M | Buy |
118,556
+33,852
| +40% | +$1.32M | 0.19% | 142 |
|
|
2021
Q4 | $3.38M | Buy |
+84,704
| New | +$3.38M | 0.14% | 180 |
|